This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohshima, K. Articles by Kimura, N. Search for Related Content PubMed PubMed Citation Articles by Ohshima, K. Articles by Kimura, N.

Defective Provirus Form of Human T-Cell Leukemia Virus Type I in Adult T-Cell Leukemia/Lymphoma: Clinicopathological Features¹

Department of Pathology [K. O., M. K., Y-i. M., S. K., Y. S., F. E., H. M., T. Y., M. T.] and Internal Medicine [N. K.], School of Medicine, Fukuoka University, Fukuoka, Japan

Human T-cell leukemia virus type I (HTLV-I) is associated with adult T-cell leukemia-lymphoma (ATLL). To examine the relationship between defective HTLV-I proviruses and clinicopathological features, we examined 95 patients with ATLL showing clonal integration of HTL-I proviral DNA; 77 patients (81%) showed 1 clonal band, 15 (16%) showed 2 clonal bands, and 3 (3%) showed 3 clonal bands. In addition, the defective proviral form was detected in 28 patients (29%): 23 (30%) of the 77 with 1 clonal band, 4(27%) of the 15 with 2 clonal bands, and 1(33%) of the 3 with 3 clonal bands. The numbers of clonal bands had no association with the presence of defective proviruses. We classified the 95 patients with ATLL into four types according to clinicopathological features (smoldering leukemia, chronic leukemia, acute leukemia, and lymphoma types). The distribution of patients with the defective form was not different among these four types. The HTLV-I genomes must have integrated into the human genome DNA and been deleted partially in the cells. The defective form was kept during the clinical stage. All patients with the defective form showed defect of the gag or/and env region. No patient had a defect of the pX region. These data suggest that the pX region of HTLV-I must have played an important role in ATLL genesis.

¹ Supported in part by a Grant-in-Aid for Encouragement of Young Scientists from the Ministry of Education, Science and Culture, Japan.

² To whom requests for reprints should be addressed, at Department of Pathology, School of Medicine, Fukuoka University, Nanakuma 7-45-1, Jyonanku, Fukuoka 814-01, Japan.

Received 1/28/91. Accepted 6/24/91.

This article has been cited by other articles:

				S. Calattini, S. A. Chevalier, R. Duprez, P. Afonso, A. Froment, A. Gessain, and R. Mahieux Human T-Cell Lymphotropic Virus Type 3: Complete Nucleotide Sequence and Characterization of the Human Tax3 Protein J. Virol., October 1, 2006; 80(19): 9876 - 9888. [Abstract] [Full Text] [PDF]

				K. Karube, K. Ohshima, J. Suzumiya, R. Kawano, M. Kikuchi, and M. Harada Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed-Sternberg (HRS) cells: high expression of interleukin-11 receptor {alpha} Ann. Onc., January 1, 2006; 17(1): 110 - 116. [Abstract] [Full Text] [PDF]

				T. Tsuchiya, K. Ohshima, K. Karube, T. Yamaguchi, H. Suefuji, M. Hamasaki, C. Kawasaki, J. Suzumiya, M. Tomonaga, and M. Kikuchi Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL Blood, January 1, 2004; 103(1): 236 - 241. [Abstract] [Full Text] [PDF]

				S. Tajima and Y. Aida The Region between Amino Acids 245 and 265 of the Bovine Leukemia Virus (BLV) Tax Protein Restricts Transactivation Not Only via the BLV Enhancer but Also via Other Retrovirus Enhancers J. Virol., December 1, 2000; 74(23): 10939 - 10949. [Abstract] [Full Text]

				D. Zucker-Franklin and B. A. Pancake Human T-Cell Lymphotropic Virus Type 1 Tax among American Blood Donors Clin. Vaccine Immunol., November 1, 1998; 5(6): 831 - 835. [Abstract] [Full Text]

				S. Tajima, Y. Ikawa, and Y. Aida Complete Bovine Leukemia Virus (BLV) Provirus Is Conserved in BLV-Infected Cattle throughout the Course of B-Cell Lymphosarcoma Development J. Virol., September 1, 1998; 72(9): 7569 - 7576. [Abstract] [Full Text] [PDF]

				S. L. Tarsis, M.-T. Yu, E. S. Parks, D. Persaud, J. L. Munoz, and W. P. Parks Human T-Lymphocyte Transformation with Human T-Cell Lymphotropic Virus Type 2 J. Virol., January 1, 1998; 72(1): 841 - 846. [Abstract] [Full Text] [PDF]

				J.H. Richardson, P. Hollsberg, A. Windhagen, L.A. Child, D.A. Hafler, and A.M.L. Lever Variable Immortalizing Potential and Frequent Virus Latency in Blood-Derived T-Cell Clones Infected With Human T-Cell Leukemia Virus Type I Blood, May 1, 1997; 89(9): 3303 - 3314. [Abstract] [Full Text] [PDF]

				K. Tsukasaki, H. Tsushima, M. Yamamura, T. Hata, K. Murata, T. Maeda, S. Atogami, H. Sohda, S. Momita, S. Ideda, et al. Integration Patterns of HTLV-I Provirus in Relation to the Clinical Course of ATL: Frequent Clonal Change at Crisis From Indolent Disease Blood, February 1, 1997; 89(3): 948 - 956. [Abstract] [Full Text] [PDF]